Methylphenidate vs Lisdexamfetamine in Australia: What’s the Difference, Onlinepharmaustralia If you are researching ADHD medication in Australia, you may have come across two commonly discussed stimulant treatments: methylphenidate and lisdexamfetamine.
Both are stimulant medicines used in ADHD treatment, but they are different medicines with different pharmacological properties and formulations.
So, which is better: methylphenidate or lisdexamfetamine?
There is no universal answer.
Australian ADHD clinical guidance recommends individualising medication selection according to the person’s symptoms, treatment response, side effects, health circumstances and preferences. Both methylphenidate and lisdexamfetamine are among the stimulant options used in Australia.
This guide explains the key differences and what patients should discuss with their healthcare professional.
Quick Answer: Methylphenidate vs Lisdexamfetamine
Both methylphenidate and lisdexamfetamine are stimulant medicines used to treat ADHD.
Methylphenidate is available in both short-acting and long-acting formulations in Australia.
Lisdexamfetamine is a long-acting stimulant medicine.
The Australian ADHD Clinical Practice Guideline states that methylphenidate, dexamfetamine and lisdexamfetamine are stimulant treatment options and recommends that medication choice and dosage be optimised for each individual. methylphenidate vs lisdexamfetamine
Neither medicine is automatically better for everyone.
What Is Methylphenidate?
Methylphenidate is a stimulant medicine used in ADHD treatment.
It is the active ingredient in several medicines available in Australia, including:
- Ritalin
- Ritalin LA
- Concerta
- other methylphenidate formulations
Healthdirect lists multiple Australian medicines containing methylphenidate.
Methylphenidate is available in both short-acting and long-acting formulations.
This gives clinicians different options when considering the duration of symptom coverage and the person’s daily routine.
What Is Lisdexamfetamine?
Lisdexamfetamine is another stimulant medicine used for ADHD.
Unlike methylphenidate, it belongs to the amphetamine family.
Healthdirect identifies lisdexamfetamine as an active ingredient used in ADHD medicines and provides information about available formulations, side effects and PBS status.
Lisdexamfetamine is a long-acting stimulant formulation.
Are Methylphenidate and Lisdexamfetamine the Same?
No.
Although both medicines are stimulants used for ADHD, they are chemically different.
Methylphenidate and lisdexamfetamine also have different pharmacological properties.
This matters because people can respond differently to each medicine.
Someone may experience good symptom control with methylphenidate but not lisdexamfetamine, or the reverse.
The Australian guideline specifically recognises that if one stimulant does not provide sufficient improvement or causes problematic side effects, another stimulant can be trialled.
Methylphenidate vs Lisdexamfetamine: Key Differences
| Feature | Methylphenidate | Lisdexamfetamine |
|---|---|---|
| Medicine type | Stimulant | Stimulant |
| ADHD use | Yes | Yes |
| Available formulations | Short- and long-acting | Long-acting |
| Active ingredient | Methylphenidate | Lisdexamfetamine |
| Drug family | Methylphenidate | Amphetamine |
| Prescription required | Yes | Yes |
| Suitable for everyone? | No | No |
| Treatment choice | Individualised | Individualised |
The Australian ADHD guideline describes all three major stimulant types available in Australia—methylphenidate, dexamfetamine and lisdexamfetamine—as broadly effective treatment options, with individual optimisation recommended.
Which Works Better for ADHD?
There is no single medication that works best for every patient.
Research reviewed by the Australian ADHD guideline found benefits from both methylphenidate and lisdexamfetamine, but comparisons do not establish that one medicine is universally superior for every person.
The guideline therefore recommends considering the individual’s:
- symptoms
- age
- treatment goals
- previous medication response
- side effects
- medical history
- daily routine
- preferences
A medication that works well for one person may not be the best choice for another.
Methylphenidate vs Lisdexamfetamine for Adults
Both medicines can be considered for adults with ADHD when medication is clinically appropriate.
The Australian ADHD guideline recommends stimulant medication as a first medication option for adults starting ADHD treatment, unless stimulants are unsuitable because of other health considerations.
For an adult choosing between methylphenidate and lisdexamfetamine, a clinician may consider:
- how long symptom coverage is required
- work schedule
- previous medication experience
- sleep
- appetite
- cardiovascular health
- other medicines
- side effects
- personal preference
The decision should be based on the individual’s clinical circumstances rather than simply choosing the medicine with the strongest reputation online.
Methylphenidate vs Lisdexamfetamine for Children
Both stimulant medicines can be used in appropriate children and adolescents.
However, children require careful assessment and monitoring.
The Australian ADHD guideline recommends monitoring treatment effectiveness and unwanted effects and paying particular attention to heart rate, blood pressure, height and weight in children.
Parents and carers should report significant changes in:
- appetite
- weight
- growth
- sleep
- mood
- behaviour
- cardiovascular symptoms
to the child’s healthcare professional.
Short-Acting vs Long-Acting ADHD Medication
One important difference between these treatments is formulation.
Methylphenidate is available in both short-acting and long-acting formulations.
Lisdexamfetamine is a long-acting stimulant.
Healthdirect explains that short-acting ADHD medicines generally work sooner but provide a shorter period of effect, while long-acting medicines are designed to provide longer-lasting coverage.
The Australian ADHD guideline’s consumer information similarly describes short-acting stimulant formulations as providing shorter coverage and long-acting formulations as providing longer coverage.
How Long Do Methylphenidate and Lisdexamfetamine Last?
Duration varies according to the particular medicine and formulation.
Short-acting methylphenidate generally has a shorter duration than long-acting stimulant formulations.
Long-acting formulations are designed to provide coverage across a larger portion of the day.
The Australian guideline’s consumer companion describes short-acting stimulant medicines as generally lasting around four hours and long-acting formulations as providing approximately 8–12 hours of coverage, although individual response varies.
These figures should not be used to change a prescription.
The actual duration experienced by an individual can vary.
Which Has Fewer Side Effects?
Neither medicine can be described as universally safer or better tolerated.
Both can cause unwanted effects.
For stimulant ADHD medicines, Healthdirect identifies possible effects including:
- reduced appetite
- headache
- stomach ache
- difficulty sleeping
- anxiety
- increased blood pressure
Weight loss can also occur.
The actual side-effect profile varies between individuals.
If one stimulant causes troublesome effects, the clinician may consider another medicine or formulation.
Methylphenidate and Appetite
Reduced appetite can occur with stimulant treatment.
This is particularly important for children and adolescents because growth and nutritional intake need to be monitored.
The Australian ADHD guideline recommends monitoring height and weight in children receiving medication.
Adults should also tell their healthcare professional about significant or persistent appetite changes.
Lisdexamfetamine and Appetite
Lisdexamfetamine can also affect appetite.
If appetite suppression becomes significant, the patient should discuss it with their healthcare professional.
The goal of treatment is effective ADHD symptom management while maintaining an acceptable balance between benefits and unwanted effects.
Methylphenidate and Sleep
Stimulant medication can affect sleep.
Some people may experience difficulty falling asleep or changes to their normal sleep pattern.
However, ADHD itself can also be associated with sleep difficulties.
If sleep becomes problematic after starting medication, speak with your healthcare professional rather than changing the treatment schedule yourself.
Lisdexamfetamine and Sleep
Lisdexamfetamine can also affect sleep in some people.
The timing of medication, individual response and other factors can influence sleep.
A clinician can determine whether changing the treatment approach is appropriate.
Can You Switch From Methylphenidate to Lisdexamfetamine?
A clinician may decide to switch treatment if methylphenidate does not provide adequate symptom improvement or causes unacceptable side effects.
The Australian ADHD guideline specifically states that if one stimulant does not improve symptoms sufficiently or produces side effects, another stimulant should be trialled.
However, patients should not switch prescription stimulant medicines independently.
The appropriate treatment plan depends on the medicine, formulation, dose and individual circumstances.
Why Might a Doctor Choose Methylphenidate First?
There is no universal rule that every patient must start with methylphenidate.
The Australian guideline allows clinicians and patients to consider methylphenidate, dexamfetamine or lisdexamfetamine as stimulant options, with the choice individualised to the person.
A clinician may consider:
- previous response
- side-effect risk
- formulation preference
- duration required
- availability
- other medical conditions
- individual treatment goals
Why Might a Doctor Choose Lisdexamfetamine?
Lisdexamfetamine may be considered when a long-acting stimulant formulation is appropriate.
The Australian ADHD guideline notes that if a short-acting stimulant is effective and well tolerated but a longer-acting formulation is more convenient or preferred, a long-acting stimulant such as lisdexamfetamine or long-acting methylphenidate may be offered.
Again, the decision is individual.
What If Neither Medicine Works?
Not everyone responds adequately to stimulant treatment.
If methylphenidate and lisdexamfetamine are ineffective or unsuitable, other treatment options may be considered.
The Australian ADHD guideline identifies dexamfetamine, and where appropriate non-stimulant medicines such as atomoxetine or guanfacine, among alternatives.
A clinician may also reassess whether another factor is contributing to ongoing symptoms.
Does ADHD Medication Need Regular Monitoring?
Yes.
Ongoing monitoring is an important part of ADHD medication treatment.
The Australian guideline recommends monitoring:
- treatment effectiveness
- unwanted effects
- heart rate
- blood pressure
- height and weight in children
and adjusting treatment when necessary.
This means ADHD treatment should not be viewed as simply receiving a prescription and continuing indefinitely without review.
Is Methylphenidate or Lisdexamfetamine Addictive?
Both are stimulant medicines and are subject to controlled-medicine requirements in Australia.
This does not mean that appropriately prescribed treatment is equivalent to recreational stimulant use.
However, medicines should be taken exactly as prescribed and never shared with another person.
Patients who have concerns about misuse, dependence or their relationship with medication should discuss those concerns openly with their healthcare professional.
Can ADHD Medication Be Used With Other Medicines?
Potential interactions depend on the specific ADHD medicine and the other medicines being taken.
Before starting treatment, tell your doctor or pharmacist about:
- prescription medicines
- over-the-counter medicines
- supplements
- herbal products
- other ADHD medicines
Your clinician can determine whether additional monitoring or treatment adjustments are required.
Which ADHD Medication Is Right for Me?
The most useful question is not:
“Which ADHD medicine is the strongest?”
It is:
“Which treatment provides meaningful symptom improvement with an acceptable safety and side-effect profile for me?”
Your healthcare professional may consider:
- Your ADHD symptoms
- Your age
- Your medical history
- Your cardiovascular health
- Your sleep
- Other medicines
- Previous ADHD treatment
- Treatment goals
- Side effects
- Your preferences
This is why two people with ADHD may receive different medicines.
Frequently Asked Questions
Is methylphenidate better than lisdexamfetamine?
Not universally. Both are stimulant options for ADHD, and the most appropriate choice depends on the individual. The Australian ADHD guideline recommends optimising medication choice and dosage for each person.
Is lisdexamfetamine stronger than methylphenidate?
“Stronger” is not a useful way to compare the two. They are different stimulant medicines with different pharmacological properties. Treatment response varies between individuals.
Which lasts longer, methylphenidate or lisdexamfetamine?
It depends on the methylphenidate formulation. Short-acting methylphenidate is shorter acting, while long-acting methylphenidate and lisdexamfetamine provide longer coverage.
Can adults take methylphenidate or lisdexamfetamine?
Yes. Both are included among stimulant treatment options for adults with ADHD when clinically appropriate.
Can you switch from Ritalin to lisdexamfetamine?
A clinician may switch treatment if clinically appropriate, particularly if the first stimulant does not provide sufficient benefit or causes unacceptable side effects. Patients should not make the switch without medical guidance.
Do both medicines cause appetite loss?
Reduced appetite is a recognised potential effect of stimulant ADHD medicines. The extent varies between individuals.
Do ADHD stimulants affect sleep?
They can. Difficulty sleeping is among the recognised potential side effects of stimulant ADHD medicines.
What happens if stimulant medication does not work?
A clinician can reassess the treatment. Another stimulant or a non-stimulant medicine may be considered depending on the individual’s circumstances.
Final Takeaway
Methylphenidate and lisdexamfetamine are both established stimulant treatment options for ADHD in Australia, but they are not the same medicine.
Methylphenidate is available in short-acting and long-acting formulations, while lisdexamfetamine is a long-acting stimulant. Both can help reduce ADHD symptoms in appropriately selected patients, but individual responses and side effects vary.
The Australian ADHD Clinical Practice Guideline recommends that medication choice and dosage be optimised for each person, with ongoing monitoring of effectiveness and unwanted effects.
If you are considering ADHD medication, speak with an appropriately qualified Australian healthcare professional about which treatment may be suitable for your individual circumstances.
Medical Disclaimer
This article is for general educational purposes and does not replace individual medical advice, diagnosis or prescribing. ADHD medicines are prescription medicines and some are controlled medicines in Australia. Do not start, stop, change or share prescription medication without appropriate medical guidance.
Authoritative Sources
Australian Government health information
Australian ADHD Clinical Practice Guideline
Healthdirect Australia
Pharmaceutical Benefits Scheme